IDBZ:LSE:LSE-iShares MSCI Brazil UCITS Dist (USD)

ETF | Others |

Last Closing

USD 23.375

Change

+0.01 (+0.05)%

Market Cap

N/A

Volume

1.56K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-1.75 (-0.94%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-3.13 (-2.62%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.12%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.87%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.45 (+0.63%)

USD 266.08B
0QZO:LSE 0QZO

-1.75 (-1.83%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.04 (-0.13%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

-1.75 (-1.04%)

USD 202.26B
0R24:LSE Intel Corp.

-0.81 (-3.45%)

USD 196.14B

ETFs Containing IDBZ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.99% 7% C- 17% F
Dividend Return 4.34% 90% A- 94% A
Total Return -11.64% 8% B- 19% F
Trailing 12 Months  
Capital Gain 0.56% 16% F 28% F
Dividend Return 5.20% 89% A- 93% A
Total Return 5.76% 22% F 34% F
Trailing 5 Years  
Capital Gain -25.36% 9% A- 22% F
Dividend Return 21.69% 94% A 94% A
Total Return -3.67% 19% F 34% F
Average Annual (5 Year Horizon)  
Capital Gain 0.18% N/A N/A 38% F
Dividend Return 5.60% N/A N/A 57% F
Total Return 5.42% N/A N/A 95% A
Risk Return Profile  
Volatility (Standard Deviation) 18.57% N/A N/A 53% F
Risk Adjusted Return 30.14% N/A N/A 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike